Trial · NCT00664326
Adverse events115
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 115
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Regorafenib (BAY73-4506) | 5 | 49 | 9 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Regorafenib (BAY73-4506) | 5 | 49 | 11 |
| other | Abdominal pain | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 13 | 49 | 37 |
| other | Abdominal pain upper | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 8 | 49 | 28 |
| other | Constipation | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 17 | 49 | 112 |
| other | Diarrhoea | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 24 | 49 | 215 |
| other | Dyspepsia | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 6 | 49 | 7 |
| other | Dysphagia | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 4 | 49 | 5 |
| other | Glossodynia | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 3 | 49 | 4 |
| other | Nausea | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 16 | 49 | 46 |
| other | Oral pain | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 6 | 49 | 35 |
| other | Stomatitis | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 15 | 49 | 108 |
| other | Vomiting | Gastrointestinal disorders | Regorafenib (BAY73-4506) | 13 | 49 | 29 |
| other | Chest pain | General disorders | Regorafenib (BAY73-4506) | 7 | 49 | 19 |
| other | Chills | General disorders | Regorafenib (BAY73-4506) | 3 | 49 | 6 |
| other | Fatigue | General disorders | Regorafenib (BAY73-4506) | 22 | 49 | 192 |
| other | Mucosal inflammation | General disorders | Regorafenib (BAY73-4506) | 6 | 49 | 11 |
| other | Oedema peripheral | General disorders | Regorafenib (BAY73-4506) | 4 | 49 | 13 |
| other | Pain | General disorders | Regorafenib (BAY73-4506) | 6 | 49 | 31 |
| other | Pyrexia | General disorders | Regorafenib (BAY73-4506) | 9 | 49 | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00664326/events